These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 25975389

  • 1. Metformin targets Axl and Tyro3 receptor tyrosine kinases to inhibit cell proliferation and overcome chemoresistance in ovarian cancer cells.
    Kim NY, Lee HY, Lee C.
    Int J Oncol; 2015 Jul; 47(1):353-60. PubMed ID: 25975389
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of IL-6/STAT3 axis and targeting Axl and Tyro3 receptor tyrosine kinases by apigenin circumvent taxol resistance in ovarian cancer cells.
    Suh YA, Jo SY, Lee HY, Lee C.
    Int J Oncol; 2015 Mar; 46(3):1405-11. PubMed ID: 25544427
    [Abstract] [Full Text] [Related]

  • 3. Anticancer effect of luteolin is mediated by downregulation of TAM receptor tyrosine kinases, but not interleukin-8, in non-small cell lung cancer cells.
    Lee YJ, Lim T, Han MS, Lee SH, Baek SH, Nan HY, Lee C.
    Oncol Rep; 2017 Feb; 37(2):1219-1226. PubMed ID: 28035396
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of Tyro3 receptor tyrosine kinase leads to the acquisition of taxol resistance in ovarian cancer cells.
    Lee C.
    Mol Med Rep; 2015 Jul; 12(1):1485-92. PubMed ID: 25815442
    [Abstract] [Full Text] [Related]

  • 5. Bufalin down-regulates Axl expression to inhibit cell proliferation and induce apoptosis in non-small-cell lung cancer cells.
    Kim NY, Suh YA, Kim S, Lee C.
    Biosci Rep; 2020 Apr 30; 40(4):. PubMed ID: 32219334
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells.
    Bansal N, Mishra PJ, Stein M, DiPaola RS, Bertino JR.
    Oncotarget; 2015 Jun 20; 6(17):15321-31. PubMed ID: 26036314
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of AXL enhances chemosensitivity of human ovarian cancer cells to cisplatin via decreasing glycolysis.
    Tian M, Chen XS, Li LY, Wu HZ, Zeng D, Wang XL, Zhang Y, Xiao SS, Cheng Y.
    Acta Pharmacol Sin; 2021 Jul 20; 42(7):1180-1189. PubMed ID: 33149145
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor.
    Yokoyama Y, Lew ED, Seelige R, Tindall EA, Walsh C, Fagan PC, Lee JY, Nevarez R, Oh J, Tucker KD, Chen M, Diliberto A, Vaaler H, Smith KM, Albert A, Li G, Bui JD.
    Cancer Res; 2019 Apr 15; 79(8):1996-2008. PubMed ID: 30723115
    [Abstract] [Full Text] [Related]

  • 12. Metformin suppresses the growth of leukemia cells partly through downregulation of AXL receptor tyrosine kinase.
    Saito T, Itoh M, Tohda S.
    Leuk Res; 2020 Jul 15; 94():106383. PubMed ID: 32460059
    [Abstract] [Full Text] [Related]

  • 13. TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma.
    Ruicci KM, Meens J, Plantinga P, Stecho W, Pinto N, Yoo J, Fung K, MacNeil D, Mymryk JS, Barrett JW, Howlett CJ, Boutros PC, Ailles L, Nichols AC.
    J Exp Clin Cancer Res; 2020 Oct 15; 39(1):217. PubMed ID: 33059733
    [Abstract] [Full Text] [Related]

  • 14. Galectin-3 Stimulates Tyro3 Receptor Tyrosine Kinase and Erk Signalling, Cell Survival and Migration in Human Cancer Cells.
    Al Kafri N, Hafizi S.
    Biomolecules; 2020 Jul 11; 10(7):. PubMed ID: 32664510
    [Abstract] [Full Text] [Related]

  • 15. Axl receptor tyrosine kinase is a novel target of apigenin for the inhibition of cell proliferation.
    Kim KC, Choi EH, Lee C.
    Int J Mol Med; 2014 Aug 11; 34(2):592-8. PubMed ID: 24926787
    [Abstract] [Full Text] [Related]

  • 16. Axl is a novel target of celastrol that inhibits cell proliferation and migration, and increases the cytotoxicity of gefitinib in EGFR mutant non‑small cell lung cancer cells.
    Lee YJ, Kim SY, Lee C.
    Mol Med Rep; 2019 Apr 11; 19(4):3230-3236. PubMed ID: 30816529
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer.
    Uribe DJ, Mandell EK, Watson A, Martinez JD, Leighton JA, Ghosh S, Rothlin CV.
    PLoS One; 2017 Apr 11; 12(7):e0179979. PubMed ID: 28727830
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer.
    Quinn JM, Greenwade MM, Palisoul ML, Opara G, Massad K, Guo L, Zhao P, Beck-Noia H, Hagemann IS, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Fuh KC.
    Mol Cancer Ther; 2019 Feb 11; 18(2):389-398. PubMed ID: 30478151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.